Viewing Study NCT02389933


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-12 @ 4:34 AM
Study NCT ID: NCT02389933
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2021-02-15
First Post: 2015-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure With Reduced Ejection Fraction (HF-rEF) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Patient Program, LCZ696, heart failure, heart failure with reduced … View